Biopsy confirms an infiltrating ductal carcinoma.

The teaching point is this: whatever biological trigger  (genetic or environmental) is present in the patient that allowed the initial cancer to grow, is still present after the therapy. Any lesion that appears subsequently should be seen with significant suspicion. There is likely no place for a Birads III diagnosis in a patient with a previous carcinoma.